Carmel Capital Partners LLC raised its holdings in Oracle Corporation (NYSE:ORCL - Free Report) by 10.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,148 shares of the enterprise software provider's stock after buying an additional 1,521 shares during the quarter. Oracle makes up approximately 1.2% of Carmel Capital Partners LLC's holdings, making the stock its 15th largest holding. Carmel Capital Partners LLC's holdings in Oracle were worth $3,531,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Harel Insurance Investments & Financial Services Ltd. grew its holdings in Oracle by 71.6% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 257,378 shares of the enterprise software provider's stock valued at $35,984,000 after buying an additional 107,404 shares during the period. Lockheed Martin Investment Management Co. grew its holdings in Oracle by 4.3% in the 1st quarter. Lockheed Martin Investment Management Co. now owns 51,350 shares of the enterprise software provider's stock valued at $7,179,000 after buying an additional 2,110 shares during the period. Private Wealth Asset Management LLC grew its holdings in Oracle by 9.2% in the 2nd quarter. Private Wealth Asset Management LLC now owns 3,817 shares of the enterprise software provider's stock valued at $835,000 after buying an additional 321 shares during the period. Cascade Investment Group Inc. purchased a new stake in Oracle in the 2nd quarter valued at about $239,000. Finally, Lockerman Financial Group Inc. purchased a new stake in Oracle in the 2nd quarter valued at about $328,000. Hedge funds and other institutional investors own 42.44% of the company's stock.
Oracle Stock Performance
Shares of NYSE:ORCL opened at $291.95 on Friday. The company has a market cap of $832.28 billion, a P/E ratio of 67.58, a PEG ratio of 3.37 and a beta of 1.53. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62. Oracle Corporation has a one year low of $118.86 and a one year high of $345.72. The business's 50-day simple moving average is $271.71 and its 200 day simple moving average is $215.37.
Oracle (NYSE:ORCL - Get Free Report) last announced its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.48 by ($0.01). The company had revenue of $14.93 billion for the quarter, compared to analysts' expectations of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business's quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, sell-side analysts forecast that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Thursday, October 9th. Oracle's dividend payout ratio (DPR) is presently 46.30%.
Insider Buying and Selling at Oracle
In related news, Director Naomi O. Seligman sold 2,222 shares of the firm's stock in a transaction dated Friday, September 26th. The stock was sold at an average price of $288.91, for a total transaction of $641,958.02. Following the sale, the director directly owned 29,225 shares in the company, valued at approximately $8,443,394.75. This trade represents a 7.07% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director William G. Parrett sold 11,500 shares of Oracle stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $306.00, for a total value of $3,519,000.00. Following the sale, the director owned 17,764 shares in the company, valued at $5,435,784. This represents a 39.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 120,769 shares of company stock worth $36,428,967. Insiders own 40.90% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the company. BNP Paribas set a $377.00 price objective on Oracle in a report on Wednesday, September 10th. Citigroup restated a "buy" rating on shares of Oracle in a report on Friday, October 10th. Melius Research raised their price objective on Oracle from $270.00 to $370.00 and gave the stock a "buy" rating in a report on Wednesday, September 10th. Wolfe Research raised their price objective on Oracle from $300.00 to $400.00 and gave the stock an "outperform" rating in a report on Wednesday, September 10th. Finally, Weiss Ratings upgraded Oracle from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday, October 8th. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $323.40.
View Our Latest Stock Analysis on ORCL
Oracle Company Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report